175 related articles for article (PubMed ID: 21167913)
1. Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.
Gu H; Wei X; Monnot AD; Fontanilla CV; Behl M; Farlow MR; Zheng W; Du Y
Neurosci Lett; 2011 Feb; 490(1):16-20. PubMed ID: 21167913
[TBL] [Abstract][Full Text] [Related]
2. The role of choroid plexus in IVIG-induced beta-amyloid clearance.
Gu H; Zhong Z; Jiang W; Du E; Dodel R; Farlow MR; Zheng W; Du Y
Neuroscience; 2014 Jun; 270():168-176. PubMed ID: 24747018
[TBL] [Abstract][Full Text] [Related]
3. Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.
Behl M; Zhang Y; Shi Y; Cheng J; Du Y; Zheng W
Neurotoxicology; 2010 Sep; 31(5):524-32. PubMed ID: 20488202
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
5. Neuronal clearance of amyloid-β by endocytic receptor LRP1.
Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G
J Neurosci; 2013 Dec; 33(49):19276-83. PubMed ID: 24305823
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
7. Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
Behl M; Zhang Y; Monnot AD; Jiang W; Zheng W
Toxicol Appl Pharmacol; 2009 Oct; 240(2):245-54. PubMed ID: 19501112
[TBL] [Abstract][Full Text] [Related]
8. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
[TBL] [Abstract][Full Text] [Related]
10. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.
Kanekiyo T; Zhang J; Liu Q; Liu CC; Zhang L; Bu G
J Neurosci; 2011 Feb; 31(5):1644-51. PubMed ID: 21289173
[TBL] [Abstract][Full Text] [Related]
12. Altered clearance of beta-amyloid from the cerebrospinal fluid following subchronic lead exposure in rats: Roles of RAGE and LRP1 in the choroid plexus.
Shen X; Xia L; Liu L; Jiang H; Shannahan J; Du Y; Zheng W
J Trace Elem Med Biol; 2020 Apr; 61():126520. PubMed ID: 32325398
[TBL] [Abstract][Full Text] [Related]
13. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
[TBL] [Abstract][Full Text] [Related]
14. Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure.
Gu H; Robison G; Hong L; Barrea R; Wei X; Farlow MR; Pushkar YN; Du Y; Zheng W
Toxicol Lett; 2012 Sep; 213(2):211-9. PubMed ID: 22796588
[TBL] [Abstract][Full Text] [Related]
15. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.
Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R
J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556
[TBL] [Abstract][Full Text] [Related]
16. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice.
Shineman DW; Zhang B; Leight SN; Pratico D; Lee VM
J Neurosci; 2008 Apr; 28(18):4785-94. PubMed ID: 18448655
[TBL] [Abstract][Full Text] [Related]
18. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.
Liu LL; Shen X; Gu H; Zhao G; Du Y; Zheng W
Fluids Barriers CNS; 2023 May; 20(1):32. PubMed ID: 37122007
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
20. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
